The clinical success rates showed an increasing trend with increasing daptomycin dose for endocarditis and foreign body/prosthetic infections (Fig. 3 ).
← all excerpts
Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry.
1
—
—